FORT WORTH, TX, AUGUST 26, 2008 – Healthpoint today announced that it has initiated a clinical trial to evaluate the effectiveness of a widely prescribed enzymatic debriding agent on healing cutaneous wounds and resulting scars. The pilot study was prompted, in part, by clinical reports of the reduced incidence of hypertrophic scars and beneficial healing properties associated with Collagenase SANTYL® Ointment.1,2
News
Tue, 08/26/2008
|
||
|
Mon, 06/30/2008
FORT WORTH, TX, JUNE 30, 2008 – The Wound Institute (TWI) today announced the launch of a new educational module “Chronic Wound Infections®”, a CE accredited, online course designed to strengthen clinicians’ diagnostic skills and enhance treatment for improved clinical outcomes. |
||
Thu, 12/20/2007
HEALTHPOINT is pleased to be a Platinum Sponsor of the Third Congress of the World Union of Wound Healing Societies (WUWHS), which will take place from 4-8 June 2008 in Toronto, Canada. |
||
|
Thu, 08/09/2007
(FORT WORTH, TX) — Michael E. Steadman, Group President and COO of DFB Branded Pharmaceuticals, a segment of Fort Worth, Texas-based DFB Pharmaceuticals, Inc., has announced that Perry M. Christensen has joined the company as Vice President, Human Resources for DFB Branded Pharmaceuticals. A multilingual, global HR executive, Mr. Christensen was most recently Director of Human Resources for Celanese Corporation, a chemical products company headquartered in Dallas. |
||
|
Tue, 05/08/2007
(FORT WORTH, TX) — Robert E. Bancroft, General Manager of HEALTHPOINT, Ltd., has announced that Joseph Santoro is now Vice President of Sales and Healthcare Systems for Healthpoint. Mr. Santoro, an 18-year wound care industry veteran, was most recently Vice President of Healthpoint Tissue Management’s Healthcare Systems group. |